Technology | Remote Monitoring | December 10, 2015

ScottCare Corp. Introduces 3-in-1 TeleSense RCM Monitor

WiFi-based remote cardiac rhythm monitor incorporates mobile cardiac telemetry, Holter and cellular event monitoring

ScottCare Corp, TeleSense RCM, WiFi remote cardiac rhythm monitor

December 10, 2015 — The ScottCare Corp. announced the recent introduction of TeleSense RCM, a three-in-one device incorporating complete mobile cardiac telemetry (MCT), Holter and cellular event monitoring. TeleSense is ideal for cardiology practices and hospitals seeking to easily and more effectively manage symptomatic and asymptomatic cardiac event patients.

With TeleSense, clinicians have the flexibility to transition as needed among the three monitoring modes (MCT, Holter and event). The system features real-time streaming for live patient visibility, auto-detection of arrhythmia events and wireless transmission of three channels of electrocardiogram (ECG) data, allowing clinicians to more accurately correlate patient symptoms to changes in electrical conduction of the heart. TeleSense can transmit up to 30 days of continuous ECG data across multiple cellular networks or utilizing a patient’s home or business WiFi network.

Events are received and triaged through ScottCare’s receiving platform. TeleSense’s Web-accessible reporting software then supports detailed and actionable reporting through daily heart rate trends; event reports; end-of-session reports; interim and summary statistics; and advanced administrative and clinical queries. Optional electronic health record (EHR) integration enables reports to be easily viewed and e-signed by the physician prior to automated transmission to any HL7-based EHR system.

TeleSense also addresses the continuous concern of patient compliance. Not only is the device comfortable to wear, it is simple to set up and configure, even remotely. Brightly-lit icons allow the patient to easily identify whether the device has sufficient power, whether leads are properly connected, if the device is recording, and the status of the WiFi or cellular connection. Patients can quickly record and immediately transmit self-identified events via a large, easily accessible button on the front of the device.

For those clinicians unable to offer patients 24-hour monitoring coverage, ScottCare’s optional dedicated monitoring labor service provides 24/7 active daily surveillance and reporting capabilities, as well as immediate access to raw patient data and completed reports from any internet connected computer.

For more information: www.scottcare.com

Related Content

Insomnia Tied to Higher Risk of Heart Disease and Stroke

Image courtesy of the American Heart Association

News | Cardiac Diagnostics | August 19, 2019
People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke,...
Evolutionary Gene Loss May Help Explain Human Predisposition to Heart Attacks
News | Cardiac Diagnostics | July 29, 2019
The loss of a single gene two to three million years ago in our ancestors may have resulted in a heightened risk of...
U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
Overlay Init